Novel Methylation Panel for the Early Detection of Colorectal Tumors in Stool DNA
Authors:
- Daniel AzuaraDADaniel Azuara
- Francisco Rodriguez-MorantaFRFrancisco Rodriguez-Moranta
- Javier de OcaJOJavier de Oca
- Antonio Soriano-IzquierdoASAntonio Soriano-Izquierdo
- Josefina MoraJMJosefina Mora
- Jordi GuardiolaJGJordi Guardiola
- Sebastiano BiondoSBSebastiano Biondo
- Ignacio BlancoIBIgnacio Blanco
- Miguel Angel PeinadoMPMiguel Angel Peinado
- Victor MorenoVMVictor Moreno
- Manel EstellerMEManel Esteller
- Gabriel CapelláGCGabriel Capellá
- 1 July 2010
- journal article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 9 (3) , 168-176
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Stool Methylation-Specific Polymerase Chain Reaction Assay for the Detection of Colorectal Neoplasia in Korean PatientsDiseases of the Colon & Rectum, 2009
- Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of diseaseBritish Journal of Cancer, 2009
- Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasmsAlimentary Pharmacology & Therapeutics, 2009
- A Novel Method to Capture Methylated Human DNA from Stool: Implications for Colorectal Cancer ScreeningClinical Chemistry, 2007
- Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylationNucleic Acids Research, 2007
- Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome bandNature Genetics, 2006
- Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?Nature Clinical Practice Oncology, 2005
- Detection of Epigenetic Changes in Fecal DNA as a Molecular Screening Test for Colorectal Cancer: A Feasibility StudyClinical Chemistry, 2004
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998